Activity of ceftobiprole against Pseudomonas aeruginosa clinical isolates from Europe collected in 2005-2006

被引：0
|
作者：
Davies, T.
Sahm, D.
Flamm, R.
Bush, K.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：S583 / S583
页数：1
相关论文
共 50 条
  • [31] Antimicrobial susceptibility testings against clinical mucoid Pseudomonas aeruginosa isolates
    Horii, T.
    26TH INTERNATIONAL CONGRESS OF CHEMOTHERAPY AND INFECTION (ICC), 2009, : 119 - 122
  • [32] Antibacterial and Antibiofilm Activities of Ceragenins against Pseudomonas aeruginosa Clinical Isolates
    Bozkurt Guzel, Cagla
    Hacioglu, Mayram
    Inci, Gozde
    Savage, Paul B.
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 16 (04) : 444 - 449
  • [33] Antagonism between clinical and environmental isolates of Pseudomonas aeruginosa against coliforms
    Martins, Vinicius Vicente
    Macarenco, Ana Carolina
    Gradella, Debora Galves
    Stehling, Eliana Guedes
    WATER SCIENCE AND TECHNOLOGY-WATER SUPPLY, 2014, 14 (01): : 99 - 106
  • [34] An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa
    Segatore, Bernardetta
    Perilli, Mariagrazia
    Larosa, Monica
    Setacci, Domenico
    Celenza, Giuseppe
    Amicosante, Gianfranco
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (04) : 374 - 376
  • [35] Rates of susceptibility of colistin and carbapenems against clinical isolates of Pseudomonas aeruginosa
    Ajibade, T.
    Oladipo, E.
    Akinade, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 134 - 134
  • [36] Antimicrobial susceptibility testings against clinical mucoid Pseudomonas aeruginosa isolates
    Horii, T.
    NEW APPROACHES IN CORONARY ARTERY DISEASE: PROCEEDINGS OF THE 8TH INTERNATIONAL CONGRESS ON CORONARY ARTERY DISEASE, 2009, : 119 - 122
  • [37] Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy-SMART 2017-2021
    Karlowsky, James A.
    Lob, Sibylle H.
    Hawser, Stephen P.
    Kothari, Nimmi
    Siddiqui, Fakhar
    Alekseeva, Irina
    DeRyke, C. Andrew
    Young, Katherine
    Motyl, Mary R.
    Sahm, Daniel F.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (07) : 1343 - 1348
  • [38] Morpholinium-based ionic liquids show antimicrobial activity against clinical isolates of Pseudomonas aeruginosa
    Clapa, Tomasz
    Michalski, Jakub
    Syguda, Anna
    Narozna, Dorota
    van Oostrum, Peter
    Reimhult, Erik
    RESEARCH IN MICROBIOLOGY, 2021, 172 (03)
  • [39] Murepavadin activity tested against contemporary (2016-17) clinical isolates of XDR Pseudomonas aeruginosa
    Sader, Helio S.
    Flamm, Robert K.
    Dale, Glenn E.
    Rhomberg, Paul R.
    Castanheira, Mariana
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2400 - 2404
  • [40] Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates
    Cabassi, Clotilde Silvia
    Sala, Andrea
    Santospirito, Davide
    Alborali, Giovanni Loris
    Carretto, Edoardo
    Ghibaudo, Giovanni
    Taddei, Simone
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2017, 16
12345